Lee H B, Blaufox M D
Department of Nuclear Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York 10461.
J Nucl Med. 1989 May;30(5):666-71.
Rats with one kidney clamped (2K1C), both kidneys clamped (2K2C), unilaterally nephrectomized with remaining kidney clamped (1K1C), and normals, were studied using 99mTc mercaptoacetyltriglycine ([ 99mTc]MAG-3) and 131I orthoiodohippurate ([131I]OIH). Clearances of [99mTc]MAG-3 and [131I]OIH were performed after constricted rats became hypertensive. Clearances were repeated after i.v. Captopril. Clearances of [99mTc]MAG-3 and [131I]OIH in normals didn't change significantly after Captopril. Clearances of [99mTc]MAG-3 and [131I]OIH decreased insignificantly after Captopril in the 2K2C model. in the 2K1C group, normal kidney clearance increased ([99mTc]MAG-3 p less than 0.01 and [131I]OIH p less than 0.025) and clamped kidney clearance decreased after inhibition ([99mTc]MAG-3, p less than 0.01, [131I]OIH p less than 0.02). Clearances increased in the 1K1C group after Captopril ([99mTc]MAG-3 p less than 0.0025 and [131I]OIH, p less than 0.001). The ratio of [99mTc]MAG-3 to [131I]OIH before Captopril was 0.81 and 0.84 after Captopril. Changes in renal function after Captopril depend on the model of renovascular hypertension and possibly the dose administered. Technetium-99m MAG-3 clearance parallels [131I]orthoiodohippurate in renovascular hypertension.
对一侧肾动脉夹闭(2K1C)、双侧肾动脉夹闭(2K2C)、单侧肾切除并夹闭剩余肾脏(1K1C)的大鼠以及正常大鼠,使用99mTc 巯基乙酰三甘氨酸([99mTc]MAG - 3)和131I 邻碘马尿酸([131I]OIH)进行研究。在夹闭大鼠出现高血压后,测定[99mTc]MAG - 3和[131I]OIH的清除率。静脉注射卡托普利后重复测定清除率。正常大鼠静脉注射卡托普利后,[99mTc]MAG - 3和[131I]OIH的清除率无显著变化。在2K2C模型中,静脉注射卡托普利后,[99mTc]MAG - 3和[131I]OIH的清除率略有下降。在2K1C组中,抑制后正常肾脏的清除率增加([99mTc]MAG - 3,P<0.01;[131I]OIH,P<0.025),夹闭肾脏的清除率下降([99mTc]MAG - 3,P<0.01;[131I]OIH,P<0.02)。1K1C组静脉注射卡托普利后清除率增加([99mTc]MAG - 3,P<0.0025;[131I]OIH,P<0.001)。卡托普利给药前[99mTc]MAG - 3与[131I]OIH的比值为0.81,给药后为0.84。卡托普利治疗后肾功能的变化取决于肾血管性高血压模型,可能还与给药剂量有关。在肾血管性高血压中,99mTc MAG - 3清除率与[131I]邻碘马尿酸清除率相似。